Learn, Analyse & Invest
only with
only with
+91
Download Orca
Camlin Fine Sciences Ltd.
Camlin Fine Sciences
₹ 0.00
0.00 (0.00)%
NSE
BSE
Chemicals
Small-cap - With a market cap of ₹25.69 Cr.
| EX-Date | Purpose |
|---|---|
| 28 05 2021 | Dividend & Audited Results |
| 13 08 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 07 02 2022 | Quarterly Results |
| 19 05 2022 | Audited Results |
| 12 08 2022 | Quarterly Results |
| 12 11 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 22 05 2023 | Audited Results |
| 11 08 2023 | Quarterly Results |
| 06 11 2023 | Quarterly Results |
| 09 02 2024 | Quarterly Results |
| 11 11 2024 | Quarterly Results |
| 22 11 2024 | Right Issue of Equity Shares & Inter alia to consider and approve (subject to regulatory/ statutory and other approvals, as may be required) the following: 1. The revision of the quantum of the proposed Rights Issue to an amount not exceeding Rs. 225 crores; and 2. Issue of any debt securities of the Company |
| 02 01 2025 | Inter alia, to consider, discuss and decide various matters in connection with the Rights Issue, including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date and timing of the Rights Issue |
| 14 02 2025 | Quarterly Results |
| 23 05 2025 | Audited Results |
| 08 08 2025 | Quarterly Results |
| 29 09 2025 | Preferential Issue of shares & Inter-alia, to consider and if thought fit, to approve the proposal for issuance of equity shares of the Company by way of preferential allotment on a private placement basis towards consideration payable for acquisition of majority equity stake in Vinpai pursuant to a share swap arrangement ( Share Swap ), in accordance with the provisions of the Companies Act, 2013, and rules made thereunder, as amended, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and such other applicable laws, and subject to statutory / regulatory approval as may be required and approval of shareholders of the Company. The Board would also consider convening an postal ballot process to seek approval of the shareholders of the Company in respect of the aforesaid proposal of preferential issue for Share Swap, as required. |
| 10 11 2025 | Quarterly Results |
| 13 02 2026 | Quarterly Results |
News
